Myxoid spindle cell sarcoma with ETV6‐NTRK3 fusion

Roland, 2016, Myxofibrosarcoma, Surg Oncol Clin N Am, 25, 775, 10.1016/j.soc.2016.05.008 Sambri, 2020, The biology of myxofibrosarcoma: state of the art and future perspectives, Oncol Res Treat, 43, 314, 10.1159/000507334 Widemann, 2018, Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: state of the Art and Perspectives, J Clin Oncol, 36, 160, 10.1200/JCO.2017.75.3467 Solomon, 2019, Identifying patients with NTRK fusion cancer, Ann Oncol, 30 Brcic, 2021, Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions, Mod Pathol, 34, 396, 10.1038/s41379-020-00657-x Forsythe, 2020, A systematic review and meta-analysis of neurotrophic tyrosine receptor kinase gene fusion frequencies in solid tumors, Ther Adv Med Oncol, 12, 10.1177/1758835920975613 Demetri, 2020, Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network, Ann Oncol, 31, 1506, 10.1016/j.annonc.2020.08.2232 Solomon, 2019, Detection of NTRK Fusions: merits and Limitations of Current Diagnostic Platforms, Cancer Res, 79, 3163, 10.1158/0008-5472.CAN-19-0372 Knezevich, 1998, A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma, Nat Genet, 18, 184, 10.1038/ng0298-184 Orbach, 2020, Spotlight on the treatment of infantile fibrosarcoma in the era of neurotrophic tropomyosin receptor kinase inhibitors: international consensus and remaining controversies, Eur J Cancer, 137, 183, 10.1016/j.ejca.2020.06.028 Hong, 2020, Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials, Lancet Oncol, 21, 531, 10.1016/S1470-2045(19)30856-3 Doebele, 2020, Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials, Lancet Oncol, 21, 271, 10.1016/S1470-2045(19)30691-6 Argani, 2000, Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors, Mod Pathol, 13, 29, 10.1038/modpathol.3880006 Yamazaki, 2019, Novel NTRK3 Fusions in Fibrosarcomas of Adults, Am J Surg Pathol, 43, 523, 10.1097/PAS.0000000000001194 Wong, 2020, NTRK-rearranged mesenchymal tumours: diagnostic challenges, morphological patterns and proposed testing algorithm, Pathology, 52, 401, 10.1016/j.pathol.2020.02.004 Siozopoulou, 2021, NTRK fusions in sarcomas: diagnostic challenges and clinical aspects, Diagnostics (Basel), 11 Lam, 2018, Molecular analysis of gene fusions in bone and soft tissue tumors by anchored multiplex PCR-based targeted next-generation sequencing, J Mol Diagn, 20, 653, 10.1016/j.jmoldx.2018.05.007 Lohberger, 2017, Establishment of a novel cellular model for myxofibrosarcoma heterogeneity, Sci Rep, 7, 44700, 10.1038/srep44700